BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 12, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 9, 2005
View Archived Issues
PET scans may help predict response to therapy in metastatic breast cancer
Read More
Inhaled insulin shows promise as an alternative to subcutaneous insulin in type 1 diabetes
Read More
Novartis reflects on Q2 activities
Read More
Thymitaq phase III study fails to meet primary endpoint
Read More
Phase IIb studies begin for PT-141 for erectile dysfunction
Read More
Two more sites join Canadian phase II study of ADH-1
Read More
Par terminates amoxicillin partnership with Advancis
Read More
Characterization of a novel VRAC inhibitor for heart disease
Read More
KBMA vaccines: novel strategy for safe protective immunity
Read More
SB-706375: novel nonpeptidic UT receptor antagonist
Read More
Antithrombotic activity of DU-176b described in several animal models
Read More
Data describing pharmacodynamic profile of TGN-255 presented
Read More
Biogen Idec and PDL form collaboration for antibody products
Read More
Novel immunomodulatory agents disclosed in recent patents
Read More
Novel agents for thrombotic disorders prepared and tested
Read More
Novel agents for treating ADHD in early development at PsychoGenics
Read More
Novel MRI agents imparted by General Hospital Corporation
Read More
Santhera and Takeda to collaborate on idebenone for Friedreich's ataxia
Read More
Pozen discontinues MT-100 development in U.S. following FDA review
Read More
Pozen submits Trexima NDA for migraine
Read More
HIV protease inhibitors have potential efficacy against opportunistic leishmaniasis infections
Read More
European orphan drug status recommended for Amplimexon
Read More
Rohto to acquire Bayer Yakuhin research center
Read More
AstraZeneca and Astex Therapeutics partner on PKB inhibitors for cancer
Read More
ISIS-301012 reduces LDL cholesterol in phase I study
Read More